The objectives of the study were to appraise the knowledge which the patients have about their hypertension, and to assess the knowledge and involvement of pharmacists in the management of the hypertensive patient. All the pharmacies in the Poitou-Charentes area were invited both to participate in a training session about arterial hypertension and asked to fill in a pharmacist's questionnaire. Furthermore, each participant was required to submit a patient's questionnaire to 20 consecutive hypertensives. A total of 104 pharmacies and 1015 hypertensive patients participated in the survey. In all, 88% of the patients (n ¼ 893) were aware of their blood pressure (BP) figures, but 68% (349/515) considered themselves wrongly, to be normalized; 39% (n ¼ 350) only had BP figures o140/90 mmHg. They said they had been poorly informed about recommended lifestyle changes. In all, 18% (n ¼ 185) were equipped with an automatic device. A total of 77% (n ¼ 779) were able to give the names of their drugs without the help of the pharmacist. Treatment-related unwanted effects were reported by 8% of the patients (n ¼ 79). Only 18% (n ¼ 29) of the pharmacists were able to provide a correct definition of hypertension. Most of them thought hypertension was well controlled in the general population and considered that both tolerance of and compliance with antihypertensive treatment were satisfactory. They could most often (80%, n ¼ 135) supply a SBPM device, but 58 (36%) only were able to provide relevant advice regarding the recommended procedures. In conclusion, The BP goals and the lifestyle modifications are poorly known by the hypertensives. Pharmacists' knowledge is frequently wrong and should be improved by appropriate training programmes.
Introduction
Hypertension, one of the reversible risk factors leading to heart attacks and stroke is a public health problem in France, affecting about 40% of the adults over the age of 55 years. 1 In well-conducted clinical trials, numerous drugs and combination therapies have demonstrated their ability to reduce blood pressure (BP) and cardiovascular morbidity and mortality. Yet control of high blood pressure (HBP) remains disappointing, averaging 30% of treated hypertensives. [2] [3] [4] Patient knowledge and awareness of BP have been described as playing important roles in the ability to achieve successful control of hypertension. 5 As systemic arterial hypertension is often totally asymptomatic, it is essential for the patient to receive clear information about both the risks associated with HBP, and the benefits expected from lifestyle changes and antihypertensive treatment. Drug-related side effects also have to be explained. The involvement of the physician in this educational process is essential, but the pharmacist is likely to play a key role in this respect too. Moreover, the pharmacist may be asked by patients to measure their BP level at the pharmacy or be asked for a self-BP-measurement (SBPM) device. It seems important to promote the use of SBPM, which could contribute to improve both patients' education and BP control rate. Many studies report successes, including medication compliance, 6 and patient satisfaction, even for elderly hypertensives. 7 Accordingly, we conducted an epidemiological survey involving the pharmacists of the PoitouCharentes area (France). The main objective of this survey was to estimate the knowledge hypertensive patients have of their HBP and its management. The secondary objectives were to estimate the knowledge of the pharmacists in this field and to evaluate their involvement in the management of hypertensives, especially in the promotion of SBPM.
Methods
Poitou-Charentes is one of 22 administrative regions, located in the middle-West of France, with a population of 1.64 million inhabitants, whose demographic and epidemiological characteristics, as compared with those of whole French population, are the following: higher mean age (20% over the age of 65 years vs 16%), resulting in a higher crude CV mortality rate (333 vs 275/100 000), but associated with a lower adjusted ischaemic heart disease mortality (standardized mortality ratio-SMR ¼ 86 and 89, for males and females, respectively).
Following the initiative of the Public Health Department of the Faculty of Medicine and Pharmacy of Poitiers, all the pharmacies (n ¼ 701) of the Poitou-Charentes area were contacted and the pharmacists invited to participate in a training session on arterial HBP. A 'Pharmacists' questionnaire ' (only one per pharmacy) had to be returned with the answer to the invitation. This questionnaire was aimed at estimating the pharmacists' knowledge about HBP, with a special reference to the definition of HBP, the control of HBP in France, the compliance with therapy, the drug-related side effects and the interest of SBPM. The questionnaire was sent back by 182 pharmacies (ie participation rate ¼ 26%) and the pharmacists of 109 pharmacies participated in the training session. Pharmacists who did not respond or were absent at the training session did not differ from those who participated, regarding the characteristics of their pharmacy (namely the number of employees) nor the size of the town.
At the end of the training session, the participants were subsequently asked to submit a questionnaire for self-completion to 20 consecutive treated hypertensives. The patients had to fill in the questionnaire without the help of the pharmacist who had only to validate the responses regarding the names of the antihypertensive drugs. This 'patients' questionnaire' gave information about: (1) the sociodemographic characteristics of the patients, (2) the cardiovascular risk factors, including HBP, (3) the patients' knowledge of BP figures, lifestyle changes, pharmacological therapy, and SBPM and (4) the involvement of the pharmacist in validating this questionnaire.
Eventually, 104 pharmacies participated in this patients' survey (ie participation rate ¼ 15%) resulting in 1015 available questionnaires, that is, an average of 10 questionnaires per pharmacy.
Statistical analyses were performed using Statview software (SAS Institute, Berkeley, CA, USA).
An unpaired Student's t-test was performed to compare continuous variables and w 2 test was used to test for differences between categorical variables. Multivariate analyses were conducted using logistic regressions. A P-value of less than 0.05 was considered to indicate statistical significance. In keeping with the previous response, the compliance with the antihypertensive treatment was not considered as a real problem by the pharmacists: indeed 69% of them (n ¼ 125) considered it to be satisfactory and only 20% (n ¼ 37) found it to be poor.
Results

Only 27% of the pharmacists (n ¼ 49) indicated that the patients 'frequently' or 'rather frequently' reported drug-related side effects. ACE-inhibitors, calcium channel blockers and beta-blockers have been reported as the worse tolerated by 22% of the pharmacists (n ¼ 40), 14% (n ¼ 25) and 8% (n ¼ 15), respectively.
Most of the pharmacists (60%, n ¼ 99/167) wished the side effects to be depicted at the treatment initiation both by the doctor and the pharmacist. In all, 25% (n ¼ 42) considered that this information should be given by the doctor, and 4% (n ¼ 7) by the pharmacist. Finally, 19 pharmacists, that is 11%, considered any information about side effects, as irrelevant.
Most of the pharmacists were convinced of the usefulness of SBPM: 131 (72%) thought this technique 'could help the doctor for the diagnosis or for the assessment of the treatment effects'; 23 pharmacists considered it was 'useless for the doctor's decision because of a lack of validation and reliability'. 116 (64%) considered it 'useful for the patients in improving the management of their HBP', whereas 40 considered it 'harmful for the patients as long as it could result in obsessional behaviour or generate extreme anxiety'. In all, 62 pharmacists pointed out the usefulness of appropriate education of the patients before delivering the device.
Faced with a request for a SBPM device, 80% of the pharmacists (135/169) indicated that they had it in stock, 18% (n ¼ 30) advised the patients to ask for some information on it to their doctor, 12% (n ¼ 21) solicited a supplier, 2% (n ¼ 4) sent them towards a specialized store.
The frequency of use most often advised by the pharmacists (87/163, ie 53%) was 'one measurement a day for 1 month': only 58 pharmacists on 163 (36%) advised a frequency of 'two measures a day during 1 week' and 11% (n ¼ 18) advised the patient to take the readings 'at anytime of the day'.
Results of the 'Patients' questionnaire'
The demographic and clinical characteristics of the hypertensive patients are given in Table 1 . In all, 42% (n ¼ 417) had just one associated risk factor, in addition to HBP, 11% (n ¼ 112) presented two additional risk factors. There were 461 (84%) postmenopausal women and 115 of them (25%) were given an hormonal replacement therapy. In all, 30% of the women of childbearing potential (24/81) were given an oral contraceptive. The follow-up of HBP was performed by the general practitioner in 53% of the cases (520/985). Among 465 patients consulting a cardiologist, 59% had no cardiovascular pathology. Of the patients, only 9% (87/1015) asked the pharmacist to measure their BP.
In all, 893 patients (88%) were aware of their BP figures (systolic and diastolic) measured during their last visit to the doctor's; 75 patients indicated a single figure and 47 gave no figure. The patients who were able to report their figures were younger (64711 years) than the patients who were unable to indicate their figures (67714 years; P ¼ 0.04) and were more likely to be male than female (92% of the men vs 85% of the women; P ¼ 0.002). Other factors, which favoured the awareness of BP figures, were the family history of HBP (90% of those with, vs 84% of those without family history; P ¼ 0.005), as well as the educational level (94% of the patients with at least a university level vs 87% of those with a lower level; P ¼ 0.02). The multivariate analysis showed that the predictive independent factors of the awareness of BP figures were the male gender (adjusted P ¼ 0.0005; OR ¼ 2.22), the high educational level (adjusted P ¼ 0.03, OR ¼ 2.35), and a family history of HBP (adjusted P ¼ 0.002, OR ¼ 1.92). Patients' age did not appear as an independent predictor.
According to BP figures reported by the patients, the mean BP of the population study was 141/ 79 mmHg. In all, 39% of the patients only (n ¼ 350/ 893) seemed to be normalized (systolic BP (SBP)o140 mmHg and diastolic (DBP)o90 mmHg).
The uncontrolled patients were older (65712 years) than the normalized patients (63711 years; P ¼ 0.02), irrespective of gender. They had a much longer history of HBP (156 vs 137 months for the normalized; P ¼ 0.03) and tended more often to be female (64% of the women vs 58% of the men; P ¼ 0.07). In 543 uncontrolled patients, 119 (13%) had figures X160/95 mmHg. Within the diabetic population, 13% (18/134) were normalized according to international recommendations (o130/ 80 mmHg). Regarding elderly people (465 years of age), 86% (412/478) had a systolic BP lower than 150 mmHg.
A total of 68% of the uncontrolled hypertensives (349/515) wrongly thought to be normalized. These subjects were older (66711 years against 63712 years; P ¼ 0.0004) and more often male (72% of the men, 58% of the women; P ¼ 0.001) in comparison with those who were aware of their poor response to therapy. Hypertensives' and pharmacists' knowledge S Ragot et al
Hypertensives were asked whether their doctor had ever informed them about the usefulness of lifestyle modifications. The results are shown in Table 2 . The involvement of a cardiologist in the management of HBP resulted in a better awareness of the deleterious role of alcohol consumption and excessive salt intake.
Of the patients, 77% (779/1015) were able to provide the name of their drugs without the help of the pharmacist. The antihypertensive drugs are described in Table 3 , as well as the attitudes of the patients towards their therapy. As shown in Figure 1 , BP normalization seemed to be inversely related to the intensity of the treatment (P ¼ 0.02): the higher the number of drugs, the lower the rate of BP normalization. The factors independently linked to the occurrence of unwanted effects were the age (OR per 10 years increase ¼ 3.3; P ¼ 0.009) and the use of a diuretic (OR ¼ 1.69; P ¼ 0.03).
Poor compliance with therapy was equally observed both in men (107/441 or 24%) and women (106/548 or 19%, NS), but was more frequent in socially active than in nonactive persons (87/ 260 ¼ 33% vs 147/744 ¼ 20%; Po0.0001), as well as in patients with side-effects than in those without side-effects (42 vs 19%; Po0.001). Hypertensives who did not take their treatment at fixed hours (71/ 990) tended to forget it more frequently than the others (24/71 ¼ 34% vs 198/919 ¼ 21%; P ¼ 0.02). Among those who often forgot to take their medication, only 13 patients reported doubling the dose the following day.
Only 185 patients (18%) owned a SBPM device. These patients had a higher educational level (Po0.001), knew their BP figures better (P ¼ 0.006) but were not better controlled than the other patients (P ¼ 0.08). Of these devices, 39% were wrist models. Among arm models (n ¼ 110), 62% were equipped with automatic inflation and 27% with a printer. Of the patients, 90% reported using the device without any rule. In all, 10% of the patients followed doctor's or pharmacist' recommendations: within this subset, 33% (n ¼ 37) used their device one to two times a week, 24% (n ¼ 27) once a month, and 13% (n ¼ 14) when they did not feel well.
Discussion
Awareness of personal BP figures and of arterial hypertension definition
In our study, the ability of patients to report their SBP and DBP figures from their last hypertensionrelated clinical visit seemed to be quite good: 88% recalled their clinic-based SBP and DBP values. From a practical point of view, it should be reminded that BP figures awareness was associated with male gender, high educational level and family BP history, a finding which could help to focus information on appropriate patients. However, because of the design of our study we were unable to verify the accuracy of these reports, according to those that their doctor had told them. On the other hand, it appeared that most uncontrolled hypertensives (68%) wrongly thought to be normalized; obviously, they were not aware of the cutoff values defining hypertension and did not know what their target SBP or DBP level should be. Our results were in total agreement with those of a Polish survey, 8 which clearly showed that hypertensive patients, compared with normotensives, were less aware of normal BP values and, consequently, accepted high BP levels as normal. Similarly, Alexander et al 9 who surveyed 2500 hypertensives from a large health maintenance organization, found hypertensive patients awareness of BP targets and current hypertensive control status to be suboptimal: of patients with uncontrolled hypertension (X140 and/or 90 mmHg), only 20% labelled their BP as high; moreover, 40% of respondents could not recall their most recent clinic-based SBP and DBP values, whereas overall 72 and 61% were unable to report a target SBP or DBP, respectively.
Interestingly, the pharmacists of our study turned out not to be aware of normal BP definition, either. In addition, they clearly overestimated BP control rate; most of them considering their patients to be normalized, whereas 39% only were actually controlled in our survey.
Therefore, the major implication of our study is the need to improve the knowledge, by patients and pharmacists, of BP figures (140/90 mmHg), which both define the hypertension status and the target to be reached with antihypertensive treatment.
Awareness of the usefulness of lifestyle changes
Since 1993, the Joint National Committee on the Detection, Evaluation and Treatment of high BP (JNC) and the Working Group Report on Primary Prevention of Hypertension have recommended four lifestyle modifications for BP control: (1) weight loss in the overweight patients, (2) reduced sodium intake, (3) increased physical activity, and (4) limited alcohol consumption.
The effectiveness of slight weight loss and moderate intensity physical activity on BP control is supported by data from two recent meta-analyses. 10, 11 In one meta-analysis, 10 slight weight loss of 4-8% was associated with a 3-mmHg decrease in SBP and DBP. Likewise, the meta-analysis of Whelton et al 11 showed aerobic exercise to be associated with 5 and 4 mmHg decreases in SBP and DBP, respectively.
The effect of alcohol reduction on BP among heavy drinkers has been evaluated in Xin's metaanalysis:
12 the overall effect size estimates were: À3.31 mmHg reduction in SBP and À2.04 mmHg reduction in DBP.
Regarding salt intake, western populations are consuming far more sodium than is needed. Randomized control trials indicate that reducing Na intake by 80-100 mmol per day from an initial intake of around 180 mmol, will reduce BP by an average of 4-6 mmHg. 13 According to the American Public Health Association, a 50% reduction in sodium in the US food supply would save at least 150 000 lives annually. 14 As shown by the PREMIER study, 15 the effects of these recommendations on BP reduction could be enhanced by combining them with the implementation of a DASH diet. Physicians play an important role in helping patients to change unhealthy lifestyles. However, the number of physicians who routinely advise their patients to change their behaviour remains rather low. In our study, the proportion of patients with an unhealthy lifestyle, who reported receiving advice from their physician to change their behaviour has ranged from 24 to 66%. Some studies [17] [18] [19] have found that doubts by physicians about the effectiveness of counselling play a major role. One can assume that, the educative role of the pharmacists regarding the four major lifestyle modifications is of great importance.
Management of antihypertensive treatment
In our study, the percentage of hypertensives who were able to report the name of their treatment without the help of the pharmacist was relatively poor (77%). Most of the patients read the summary of the product characteristics and half of them needed explanations. For that, they regarded the physician as the primary source of information. Some studies [20] [21] [22] have shown that patients express a desire to be given information by pharmacy personnel as well as by physicians. In contrast, a Swedish study in hypertensive patients showed that the physician was the person from whom the patients preferred to receive information about medicines 23 and that pharmacy personnel were not regarded as an information resource. One possible reason may be that, in many pharmacies, it is difficult to communicate without disturbance, as the physical information environment is often poor. In all, 11% of the pharmacists in this study considered that giving information about side effects at the beginning of the treatment was irrelevant; accordingly, it has been found, in a British community, that the patient is seldom given information on side effects. 21 However, knowledge of the possible side effects of medication seems to be a major requirement in hypertensive patients. 23, 24 Interestingly, logistic regression showed diuretics to be independently associated with a poor tolerability, whereas pharmacists did not point out this drug class.
Our results concerning compliance with treatment of these patients who came to the pharmacy appeared to be rather far from perfect: as shown in Table 3 , 79% of the patients stated that they never missed a dose, a finding consistent with other studies. 25, 26 Pharmacists were not sufficiently aware of this problem and therefore should be trained to identify patients likely to be poorly compliant, that is, the socially active patients and those with side effects.
In keeping with Dusing's study, 27 our study showed inadequate BP control to be the most important reason for the change in therapy last year. Of note, modification of treatment was not explained by the doctor in 10% of the cases; this result emphasized the need to improve the physician-patient relationship, as suggested elsewhere. 28 
Self-BP measurement
The first international consensus conference on SBPM 29 and the last European guidelines for the management of arterial hypertension 30 have clearly established the usefulness of SBPM. In short, SBPM has been shown both to have a high predictive value for ruling out the diagnosis of 'white coat' hypertension, and to be useful in the follow-up of treated hypertensive patients.
However, several investigators have drawn attention to the risk of over-frequent measurements, possibly leading to obsession. 31, 32 Consistently, some pharmacists in our study (n ¼ 40) were aware of this problem and ticked the item SBPM is 'harmful for the patient as long as it could result in obsessional behaviour or generate extreme anxiety'.
In our study, only 18% of the patients owned a BP monitor and the proportion of wrist monitors was quite high. These devices have been described as being easier to use than conventional arm monitors by many patients. 32 Nevertheless, according to the ESH 33 this type of device is not recommended as it measures BP over the radial rather than the brachial artery and is very much more position dependent. In France, a shortlist of the validated devices is brought up to date every 6 months and is available on the web (http://www.automesure.com). Obviously, all pharmacists should be strongly requested to consult this list before giving any advice to a patient. The patients need to be correctly trained; the pharmacist could assume this training.
How to improve patients' knowledge and hypertension management Cuspidi et al 34 have shown the positive impact of a single educational meeting on patients' knowledge about issues related to hypertension. However, they did not verify the potential role of this improvement on clinical outcomes. In contrast, Palumbo et al 35 showed that hypertensive patients' knowledge is not improved by written material even when handed over by their specialist physicians. Likewise, a Japanese comparative study 36 failed to show any effect of a periodic newsletter on the persistence with therapy for 1 year.
Involving pharmacists in hypertension management could result in an increase of control rates. 37, 38 Pharmacy-based health promotion programmes in hypertension are currently implemented in Canada and USA; they are much more infrequent in Europe. The majority have been shown to improve outcomes in hypertension, by improving adherence and reducing BP levels. Nevertheless, a study 39 showed that the impact of such a pharmacist intervention is largely conditioned by patients' income status: the low-income group did not appear to benefit from the programme. These programmes are not only effective, but also efficient: a programme, 40 which consisted in the pharmacist measuring and recording the patient's BP and assessing adherence to drug treatment each time the patient came to the pharmacy to refill his/ her antihypertensive medication, showed benefits of about 10 times higher than costs.
According to the results of our survey, the following topics could be especially highlighted in a training programme for improving the management of hypertensive patients by the pharmacists: clinical definition of optimal BP, normal BP and hypertension; methodology of SBPM (shortlist of validated devices, frequency and technique of measurement, transmission of the results to the doctor), interest of lifestyle changes, patient information about unwanted effects of pharmacological treatment, importance of drug compliance and risk of an acute withdrawal, rationale of combination therapies y
Conclusion
Implementation of management programmes in hypertension in accordance with current guidelines needs the participation of the patients themselves. The quality of hypertensive care in terms of its capacity to produce knowledgeable and autonomous patients remains questionable.
Pharmacists, positioned as the most accessible health care providers in the community, could improve patients' knowledge and adherence to the management of HBP.
The knowledge of the pharmacists, as evaluated in our study, is frequently insufficient; then, appropriate training programmes should be widely developed, in order to incorporate them as a core component of the health care services.
What is known on this topic
The importance of hypertensive patients' knowledge and awareness of blood pressure. The usefulness of SBPM to improve both patients' education and BP control rate. The effectiveness of pharmacy-based health promotion programmes in hypertension in Canada and USA.
What this study adds
Patients showed a good ability to report BP figures but the majority of not normalized patients did not know current target BP levels, nor lifestyle modifications. About one of five patients only owned a SBPM device and most of them used the device inappropriately. Pharmacists' knowledge regarding hypertension management was poor but most of them wished to be involved in the information about treatment side effects and were convinced of the usefulness of SBPM.
